Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C20H21N5O6 |
Molecular Weight | 427.4106 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=NC2=C(C(CCC3=CC=C(C=C3)C(=O)N[C@@H](CCC(O)=O)C(O)=O)=CN2)C(=O)N1
InChI
InChIKey=WBXPDJSOTKVWSJ-ZDUSSCGKSA-N
InChI=1S/C20H21N5O6/c21-20-24-16-15(18(29)25-20)12(9-22-16)6-3-10-1-4-11(5-2-10)17(28)23-13(19(30)31)7-8-14(26)27/h1-2,4-5,9,13H,3,6-8H2,(H,23,28)(H,26,27)(H,30,31)(H4,21,22,24,25,29)/t13-/m0/s1
Molecular Formula | C20H21N5O6 |
Molecular Weight | 427.4106 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 1 / 1 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:47:00 UTC 2023
by
admin
on
Fri Dec 15 15:47:00 UTC 2023
|
Record UNII |
04Q9AIZ7NO
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
EMA ASSESSMENT REPORTS |
PEMETREXED LILLY (AUTHORIZED: CARCINOMA, NON-SMALL-CELL LUNG, MESOTHELIOMA)
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
ALIMTA (AUTHORIZED: CARCINOMA, NON-SMALL-CELL LUNG, MESOTHELIOMA)
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
||
|
WHO-ATC |
L01BA04
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
||
|
NDF-RT |
N0000000111
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
||
|
LIVERTOX |
NBK548117
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
||
|
NCI_THESAURUS |
C2021
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
PEMETREXED HOSPIRA (AUTHORIZED: CARCINOMA, NON-SMALL-CELL LUNG, MESOTHELIOMA)
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
||
|
NCI_THESAURUS |
C511
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
||
|
NDF-RT |
N0000175584
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
||
|
WHO-VATC |
QL01BA04
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
||
|
EMA ASSESSMENT REPORTS |
PEMETREXED MEDAC (AUTHORIZED: CARCINOMA, NON-SMALL-CELL LUNG, MESOTHELIOMA)
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
m8456
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
PRIMARY | Merck Index | ||
|
C085586
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
PRIMARY | |||
|
2073
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
PRIMARY | |||
|
135410875
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
PRIMARY | |||
|
04Q9AIZ7NO
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
PRIMARY | |||
|
Pemetrexed
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
PRIMARY | |||
|
7675
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
PRIMARY | |||
|
63616
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
PRIMARY | |||
|
68446
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
PRIMARY | RxNorm | ||
|
04Q9AIZ7NO
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
PRIMARY | |||
|
6837
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
PRIMARY | |||
|
PEMETREXED
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
PRIMARY | |||
|
137281-23-3
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
PRIMARY | |||
|
698037
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
PRIMARY | |||
|
CHEMBL1201258
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
PRIMARY | |||
|
100000085475
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
PRIMARY | |||
|
DTXSID2048329
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
PRIMARY | |||
|
SUB09655MIG
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
PRIMARY | |||
|
DB00642
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
PRIMARY | |||
|
C61614
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
PRIMARY | |||
|
7316
Created by
admin on Fri Dec 15 15:47:00 UTC 2023 , Edited by admin on Fri Dec 15 15:47:00 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BINDER->LIGAND |
BINDING
|
||
|
EXCRETED UNCHANGED |
URINE
|
||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
TRANSPORTER -> SUBSTRATE | |||
|
TARGET -> INHIBITOR | |||
|
TRANSPORTER -> SUBSTRATE | |||
|
SALT/SOLVATE -> PARENT | |||
|
SOLVATE->ANHYDROUS | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT | |||
|
TARGET -> INHIBITOR | |||
|
TARGET -> INHIBITOR | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
---|---|---|---|---|---|---|
Vdss | PHARMACOKINETIC |
|
|
|||
Biological Half-life | PHARMACOKINETIC |
|
Elimination: CrCl 40-59 mL/minute PHARMACOKINETIC PHARMACOKINETIC |
|
||